Evidence map›Paper›PMID 24726560›Full record

ReviewThe Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases

Theories about evolutionary origins of human hepatitis B virus in primates and humans.

Breno Frederico de Carvalho Dominguez Souza, Jan Felix Drexler, Renato Santos de Lima, Mila de Oliveira Hughes Veiga do Rosário, Eduardo Martins Netto

Open access · goldAbstract readReview
In one paragraph

Review in The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. A Review: The Antiviral Activity of Cyclic Peptides.International journal of peptide research and therapeutics · 2023
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Breno Frederico de Carvalho Dominguez SouzaInfectious Diseases Research Laboratory, University Hospital Professor Edgard Santos, Universidade Federal da Bahia, Salvador, BA, Brazil.
Jan Felix DrexlerInstitute of Virology, University of Bonn Medical Centre, Bonn, Germany.
Renato Santos de LimaUniversidade Federal da Bahia, Salvador, BA, Brazil.
Mila de Oliveira Hughes Veiga do RosárioInfectious Diseases Research Laboratory, University Hospital Professor Edgard Santos, Universidade Federal da Bahia, Salvador, BA, Brazil.
Eduardo Martins NettoInfectious Diseases Research Laboratory, University Hospital Professor Edgard Santos, Universidade Federal da Bahia, Salvador, BA, Brazil. Electronic address: enetto@ufba.br.
Universidade Federal da Bahia · BRUniversity of Bonn · DEComplexo Hospitalar Universitário Professor Edgard Santos · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe human hepatitis B virus causes acute and chronic hepatitis and is considered one of the most serious human health issues by the World Health Organization, causing thousands of deaths per year. There are similar viruses belonging to the Hepadnaviridae family that infect non-human primates and other mammals as well as some birds. The majority of non-human primate virus isolates were phylogenetically close to the human hepatitis B virus, but like the human genotypes, the origins of these viruses remain controversial. However, there is a possibility that human hepatitis B virus originated in primates. Knowing whether these viruses might be common to humans and primates is crucial in order to reduce the risk to humans.

objectiveTo review the existing knowledge about the evolutionary origins of viruses of the Hepadnaviridae family in primates.

methodsThis review was done by reading several articles that provide information about the Hepadnaviridae virus family in non-human primates and humans and the possible origins and evolution of these viruses.

resultsThe evolutionary origin of viruses of the Hepadnaviridae family in primates has been dated back to several thousand years; however, recent analyses of genomic fossils of avihepadnaviruses integrated into the genomes of several avian species have suggested a much older origin of this genus.

conclusionSome hypotheses about the evolutionary origins of human hepatitis B virus have been debated since the '90s. One theory suggested a New World origin because of the phylogenetic co-segregation between some New World human hepatitis B virus genotypes F and H and woolly monkey human hepatitis B virus in basal sister-relationship to the Old World non-human primates and human hepatitis B virus variants. Another theory suggests an Old World origin of human hepatitis B virus, and that it would have been spread following prehistoric human migrations over 100,000 years ago. A third theory suggests a co-speciation of human hepatitis B virus in non-human primate hosts because of the proximity between the phylogeny of Old and New World non-human primate and their human hepatitis B virus variants. The importance of further research, related to the subject in South American wild fauna, is paramount and highly relevant for understanding the origin of human hepatitis B virus.

Indexed as

Evolution, MolecularAnimalsGenotypeHepatitis B virusHumansPhylogenyPhylogeographyPrimatesEvolutionary originsHepadnaviridaeHepatitis B virusNon-human primates

Identifiers

PMID24726560
PMCPMC9428206
OpenAlexW2072993779

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.